Taking the PPAR signaling pathway as an example, previous studies demonstrated that XQ-1H (a novel derivative of ginkgolide B) could alleviate ischemic stroke by balancing pro/anti-inflammatory microglia polarization via the PPARγ pathway both in vivo and in vitro, providing an alternative medication for stroke [56]. The gene discussed is PPARA; the disease is stroke disorder.